|
⚲
|
| Keyboard |
| Keswani Sanjay Chandru
✚
|
|
|---|---|
| CIK # | 0001818524 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001818524] | |
| 4 | [0001818524] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Keswani Sanjay Chandru | |
| Neurocrine Biosciences Inc | |
| Annexon Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2026-02-13 | Grant | 6,285 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2026-02-13 | Grant | 35,827 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Restricted Stock Unit · derivative
|
2025-06-02 | Grant | 12,846 | $0.00 | |
|
Neurocrine Biosciences Inc NBIX
Stock Option · derivative
|
2025-06-02 | Grant | 70,101 | $0.00 | |
|
Annexon Inc ANNX
Common Stock
|
2022-02-11 | Grant | 12,500 | $0.00 | |
|
Annexon Inc ANNX
Stock Option (Right to Buy) · derivative
|
2022-02-11 | Grant | 100,000 | $0.00 | |
|
Annexon Inc ANNX
Common Stock
|
2021-03-24 | Sell | 3,995 | $30.17 | 120,529 |
|
Annexon Inc ANNX
Stock Option (Right to Buy) · derivative
|
2021-03-24 | Option exercise | 3,995 | $0.00 | |
|
Annexon Inc ANNX
Common Stock
|
2021-03-24 | Option exercise | 3,995 | $7.49 | 29,923 |
|
Annexon Inc ANNX
Stock Option (Right to Buy) · derivative
|
2021-02-25 | Grant | 115,000 | $0.00 |